The iconic rise of Viagra has firmly established as a symbol of pharmaceutical success, but its legacy within the broader industry now raises questions about potential returns . Generic versions are undercutting market share, prompting anxieties that investing in companies closely tied to Viagra's once-dominant position could be a speculative decis